cinacalcet follow-on compounds (Amgen)

N/A

Report date: 2025/03/14 20:00:48
NME

Base Information

Drug Namecinacalcet follow-on compounds (Amgen)
Drug Alias Namecalcimimetics (Amgen)parathyroid hormone release inhibitors (Amgen)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCalcium sensing receptor agonists
TargetsCalcium sensing receptor
Therapy Area/IndicationsHyperparathyroidism, Secondary
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAmgen Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAmgen Inc
Active IndicationsN/A
Inactive IndicationsHyperparathyroidism, Secondary

Other Information

ATC CodeN/A
Related LinksN/A